Lifecare Employee Share Purchase Program – Subscriptions by Primary Insiders – Increase of share capital

Bergen, Norway 15.7.22

Reference is made to Stock Exchange Announcement 23 May 2022 regarding the
establishment of Lifecare Group incentive program. 

All employees in the Lifecare Group have been invited to participate in
Lifecares Employee Share Purchase Program 2022 and individually subscribe for up
to 20 000 shares with a 25% discount off the volume weighted average share price
(VWAP) calculated 10 days prior to end of the subscription period (30 June
2022).

9 employees in the Lifecare Group have accepted to participate and subscribed
for in total 124 719 shares, of which the primary insiders Joacim Holter
(Lifecare CEO) and Prof. Andreas Pfützner (Lifecare CSO) both have subscribed
for the maximum offering of 20 000 shares. 

The price per share under Lifecares Employee Share Purchase Program 2022 has
been calculated to NOK 3,22962, taking the VWAP and discount into consideration.
All shares under the Lifecare Employee Share Purchase Program 2022 have a lock
up period of 12 months. 

Based on board authorization granted by the General Meeting of Lifecare 6 May
2022, Lifecares' Board of Directors passed a resolution to issue 124 719 shares
for an aggregated subscription price of NOK 402 794,98, corresponding to a price
per share of NOK 3,22962.  

Following the issuance of the new shares, the Company will have 99 865 742
shares outstanding, each with a nominal value of NOK 0,40. The total share
capital of the Company will be NOK 39 946 296,20. The Company's Articles of
Associations will be updated accordingly.   

The share issuance is expected to be completed by 15. August 2021. 

Further information
Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act. This stock exchange announcement was
published by Joacim Holter, CEO at Lifecare AS, on 15.7.2022 at 13:35 CET.